Upstream Bio, Inc.
UPB
$8.95
-$0.16-1.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.85M | 2.80M | 2.72M | 2.30M | 2.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.85M | 2.80M | 2.72M | 2.30M | 2.37M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 2.85M | 2.80M | 2.72M | 2.30M | 2.37M |
| SG&A Expenses | 26.41M | 24.90M | 23.43M | 19.99M | 17.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 163.22M | 143.31M | 124.29M | 97.06M | 80.13M |
| Operating Income | -160.36M | -140.51M | -121.57M | -94.76M | -77.76M |
| Income Before Tax | -143.44M | -122.23M | -104.47M | -79.18M | -62.81M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -143.44 | -122.23 | -104.47 | -79.18 | -62.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -143.44M | -122.23M | -104.47M | -79.18M | -62.81M |
| EBIT | -160.36M | -140.51M | -121.57M | -94.76M | -77.76M |
| EBITDA | -160.17M | -140.33M | -121.42M | -94.65M | -77.68M |
| EPS Basic | -2.66 | -2.64 | -7.30 | -10.40 | -14.57 |
| Normalized Basic EPS | -1.66 | -1.46 | -4.38 | -6.96 | -8.92 |
| EPS Diluted | -2.66 | -2.64 | -7.30 | -10.40 | -14.57 |
| Normalized Diluted EPS | -1.66 | -1.46 | -4.38 | -6.96 | -8.92 |
| Average Basic Shares Outstanding | 215.41M | 207.02M | 156.11M | 105.35M | 54.73M |
| Average Diluted Shares Outstanding | 215.41M | 207.02M | 156.11M | 105.35M | 54.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |